Steward Partners Investment Advisory’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$133 Buy
102
+1
+1% +$1 ﹤0.01% 4548
2026
Q1
$130 Hold
101
– – ﹤0.01% 4337
2025
Q4
$223 Hold
101
– – ﹤0.01% 4192
2025
Q3
$164 Buy
+101
New +$211 ﹤0.01% 4177

Other funds holding LUNG

Steward Partners Investment Advisory's LUNG Position: Q2 2026 in Review

Steward Partners Investment Advisory increased its Pulmonx (LUNG) stake by 0.99% in Q2 2026, buying an estimated $1 and bringing the position to 102 shares worth $133. The position accounts for ﹤0.01% of the portfolio, ranked #4548.

Steward Partners Investment Advisory first reported a position in LUNG in Q3 2025 and has held it in 4 quarters since. The position peaked at $223 in Q4 2025. 107 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Steward Partners Investment Advisory held 102 shares of Pulmonx worth $133 as of Q2 2026.
  • Steward Partners Investment Advisory bought 1 Pulmonx share in Q2 2026, an estimated $1.
  • Pulmonx made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #4548 holding.
  • Steward Partners Investment Advisory first reported a position in Pulmonx in Q3 2025 and has held it in 4 quarters since.
  • Steward Partners Investment Advisory's Pulmonx position peaked at $223 in Q4 2025.
  • 107 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.